Full restoration of Brucella-infected dendritic cell functionality through Vγ9Vδ2 T helper type 1 crosstalk

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ni, Ming ^a,b   Martire, Delphine ^a,b   Scotet, Emmanuel ^c   Bonneville, Marc ^c   Sanchez, Francoise ^a,b   Lafont, Virginie ^a,b  

^a UNIV MONTPELLIER   (France)

^b University of Montpellier I and II   (France)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRUCELLA SUIS; BRUCELLOSIS; CELL ACTIVATION; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL THERAPY; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; OUTCOME ASSESSMENT; TH1 CELL;

BRUCELLA; CELL PROLIFERATION; DENDRITIC CELLS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; RECEPTOR CROSS-TALK; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865199614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043613     Document Type: Article

References (36)

1. Bukowski JF, Morita CT, Brenner MB, ((1999)) Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity 11:: 57--65.
2. Jomaa H, Feurle J, Luhs K, Kunzmann V, Tony HP, et al. ((1999)) Vgamma9/Vdelta2 T cell activation induced by bacterial low molecular mass compounds depends on the 1-deoxy-D-xylulose 5-phosphate pathway of isoprenoid biosynthesis. FEMS Immunol Med Microbiol 25:: 371--378.
3. Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR, ((1995)) Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375:: 155--158.
4. Sicard H, Fournie JJ, ((2000)) Metabolic routes as targets for immunological discrimination of host and parasite. Infect Immun 68:: 4375--4377.
5. Holoshitz J, Romzek NC, Jia Y, Wagner L, Vila LM, et al. ((1993)) MHC-independent presentation of mycobacteria to human gamma delta T cells. Int Immunol 5:: 1437--1443.
6. Morita CT, Beckman EM, Bukowski JF, Tanaka Y, Band H, et al. ((1995)) Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 3:: 495--507.
7. Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, et al. ((2000)) Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96:: 384--392.
8. Kunzmann V, Bauer E, Wilhelm M, ((1999)) Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 340:: 737--738.
9. Thompson K, Rogers MJ, ((2004)) Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro. J Bone Miner Res 19:: 278--288.
10. Scotet E, Martinez LO, Grant E, Barbaras R, Jeno P, et al. ((2005)) Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 22:: 71--80.
11. Bonneville M, O'Brien RL, Born WK Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 10:: 467--478.
12. Banchereau J, Steinman RM, ((1998)) Dendritic cells and the control of immunity. Nature 392:: 245--252.
13. Billard E, Dornand J, Gross A, ((2007)) Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion. Infect Immun 75:: 4980--4989.
14. Salcedo SP, Marchesini MI, Lelouard H, Fugier E, Jolly G, et al. ((2008)) Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathog 4:: e21.
15. Hanekom WA, Mendillo M, Manca C, Haslett PA, Siddiqui MR, et al. ((2003)) Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. J Infect Dis 188:: 257--266.
16. Shannon JG, Howe D, Heinzen RA, ((2005)) Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule. Proc Natl Acad Sci U S A 102:: 8722--8727.
17. Devilder MC, Maillet S, Bouyge-Moreau I, Donnadieu E, Bonneville M, et al. ((2006)) Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. J Immunol 176:: 1386--1393.
18. Ismaili J, Olislagers V, Poupot R, Fournie JJ, Goldman M, ((2002)) Human gamma delta T cells induce dendritic cell maturation. Clin Immunol 103:: 296--302.
19. Dunne MR, Madrigal-Estebas L, Tobin LM, Doherty DG (E)-4-hydroxy-3-methyl-but-2 enyl pyrophosphate-stimulated Vgamma9Vdelta2 T cells possess T helper type 1-promoting adjuvant activity for human monocyte-derived dendritic cells. Cancer Immunol Immunother 59:: 1109--1120.
20. Bennouna J, Bompas E, Neidhardt EM, Rolland F, Philip I, et al. ((2008)) Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother 57:: 1599--1609.
21. Dieli F, Vermijlen D, Fulfaro F, Caccamo N, Meraviglia S, et al. ((2007)) Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res 67:: 7450--7457.
22. Kobayashi H, Tanaka Y, Yagi J, Osaka Y, Nakazawa H, et al. ((2007)) Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study. Cancer Immunol Immunother 56:: 469--476.
23. Atluri VL, Xavier MN, de Jong MF, den Hartigh AB, Tsolis RE Interactions of the human pathogenic Brucella species with their hosts. Annu Rev Microbiol 65:: 523--541.
24. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV, ((2006)) The new global map of human brucellosis. Lancet Infect Dis 6:: 91--99.
25. Oliaro J, Dudal S, Liautard J, Andrault JB, Liautard JP, et al. ((2005)) Vgamma9Vdelta2 T cells use a combination of mechanisms to limit the spread of the pathogenic bacteria Brucella. J Leukoc Biol 77:: 652--660.
26. Dudal S, Turriere C, Bessoles S, Fontes P, Sanchez F, et al. ((2006)) Release of LL-37 by activated human Vgamma9Vdelta2 T cells: a microbicidal weapon against Brucella suis. J Immunol 177:: 5533--5539.
27. Ottones F, Dornand J, Naroeni A, Liautard JP, Favero J, ((2000)) V gamma 9V delta 2 T cells impair intracellular multiplication of Brucella suis in autologous monocytes through soluble factor release and contact-dependent cytotoxic effect. J Immunol 165:: 7133--7139.
28. Billard E, Cazevieille C, Dornand J, Gross A, ((2005)) High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infect Immun 73:: 8418--8424.
29. Lafont V, Liautard J, Sable-Teychene M, Sainte-Marie Y, Favero J, ((2001)) Isopentenyl pyrophosphate, a mycobacterial non-peptidic antigen, triggers delayed and highly sustained signaling in human gamma delta T lymphocytes without inducing eown-modulation of T cell antigen receptor. J Biol Chem 276:: 15961--15967.
30. Dieli F, Troye-Blomberg M, Ivanyi J, Fournie JJ, Krensky AM, et al. ((2001)) Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis 184:: 1082--1085.
31. Viey E, Fromont G, Escudier B, Morel Y, Da Rocha S, et al. ((2005)) Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma. J Immunol 174:: 1338--1347.
32. Mattarollo SR, Kenna T, Nieda M, Nicol AJ, ((2007)) Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity. Cancer Immunol Immunother 56:: 1285--1297.
33. Morel Y, Truneh A, Sweet RW, Olive D, Costello RT, ((2001)) The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol 167:: 2479--2486.
34. Wurtzen PA, Nissen MH, Claesson MH, ((2001)) Maturation of dendritic cells by recombinant human CD40L-trimer leads to a homogeneous cell population with enhanced surface marker expression and increased cytokine production. Scand J Immunol 53:: 579--587.
35. Conti L, Casetti R, Cardone M, Varano B, Martino A, et al. ((2005)) Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J Immunol 174:: 252--260.
36. Meraviglia S, Caccamo N, Salerno A, Sireci G, Dieli F, ((2010)) Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cells. J Immunol 185:: 1770--1776.